Psychopharmacology Archives - Page 3 of 7

The Neurobiology Of Endocannabinoids

Video June 17, 2019

Hear from Chloe Liu, Ph.D., a Medical Science Liaison with Otsuka Pharmaceutical Development & Commercialization, Inc., as she examines the historical research discoveries and underlying neurobiological mechanisms of the endocannabinoid… Read More

Revisiting Cognitive Deficits In Bipolar Disorder

On-Demand Webinar June 11, 2019

Neurocognitive deficits are commonly experienced by individuals living with bipolar disorder. Bipolar disorder is known to affect attention, processing speed, verbal learning and memory, and executive functions, including working memory… Read More

The Neurobiology Of Opioids

Video June 10, 2019

Hear from Chip Meyer, Ph.D., a Medical Science Liaison with Otsuka Pharmaceutical Development & Commercialization, Inc., as he examines the historic medical utilization and underlying neurobiological mechanisms of opioids. Explore… Read More

Giving Mental Illness A Voice: Patient Perspectives On Self-Disclosure & Stigma

On-Demand Webinar May 23, 2019

Individuals living with mental illness often struggle with disclosing their mental health condition to others like friends, family, and employers, due to stigma. This stigmatization may impact the individual in… Read More

State Of The Science 2019: REMS & Other Hot Topics In Bipolar Disorder Treatment

Interview May 22, 2019

PsychU Section Advisor Dr. Terence Ketter takes a moment to share his insights into treatment and science advances in the field of bipolar disorder research. He touches on risk evaluation… Read More

State Of The Science 2019: Where Are We With Depression Care In The United States?

Interview May 6, 2019

Care for major depressive disorder (MDD) has come a long way. The mental health field continues to make new strides in the understanding of the underlying pathology and potential treatment… Read More

Benefits & Challenges Of Smartphone Use In Mental Health

On-Demand Webinar May 1, 2019

Pew Research Center statistics indicate that 95% of Americans now own some type of cellphone, and that 77% are smartphones.1 Increases in digital adoption for residents in the U.S. certainly… Read More

After A Natural Disaster Or Tragedy: Behavioral Health Response Immediately Following A Mass Shooting (Part 8 Of 9)

Interview April 29, 2019

In this interview, Deborah Blalock describes the behavioral health services immediately provided following the mass shooting which occurred on June 17, 2015 at Mother Emanuel AME in Charleston, SC. She… Read More

After A Natural Disaster Or Tragedy: Long-Term Behavioral Health Services In Response To A Mass Shooting (Part 9 Of 9)

Interview April 29, 2019

In this interview, Deborah Blalock describes the long-term behavioral health services being provided in her community, to the congregation and first responders impacted, in response to the mass shooting on… Read More

The Role Of Glutamate In Mood Disorders & Schizophrenia

On-Demand Webinar March 19, 2019

Glutamate is the predominant excitatory neurotransmitter in the nervous system, and glutamatergic dysregulation has been implicated in the pathophysiology of both mood disorders and schizophrenia. In this webinar, Dr. James… Read More

Now Leaving PsychU

This link will take you outside of the PsychU community website

PsychU

Sorry, this content is no longer available.

Stay Connected: